Related Experiment Videos
Pulmonary hypertension and cor pulmonale
1Division of Pulmonary and Critical Care (8381), University of California, San Diego, Medical Center 92103, USA.
Current Opinion in Pulmonary Medicine
|July 1, 1995
Summary
Pulmonary hypertension involves endothelial cell dysfunction and mediator imbalance. Recent research explores novel therapies and surgical options for managing this complex vascular disease.
Area of Science:
- Cardiovascular Medicine
- Pulmonary Medicine
- Vascular Biology
Background:
- Pulmonary hypertensive disease pathogenesis involves complex pathophysiologic mechanisms.
- Pulmonary endothelial cells play a critical role in vascular tone regulation and small vessel changes.
- Imbalances in endothelium-derived mediators like nitric oxide, prostacyclin, and endothelin-1 contribute to abnormal pulmonary vascular tone and structure.
Purpose of the Study:
- To highlight recent advancements in understanding pulmonary vascular pathophysiology.
- To examine current strategies for the evaluation and treatment of pulmonary hypertension and cor pulmonale.
Main Methods:
- Review of recent scientific literature on pulmonary hypertension.
- Analysis of evolving insights into pulmonary vascular physiology.
- Examination of novel therapeutic and surgical strategies.
Main Results:
- New insights into the pathophysiologic mechanisms of pulmonary hypertensive disease.
- Identification of the central role of pulmonary endothelial cells.
- Understanding the importance of endothelium-derived mediators in disease development.
Conclusions:
- Evolving understanding of pulmonary vascular physiology drives novel therapeutic strategies.
- Advances in surgical technologies offer expanded treatment options for selected patients.
- Comprehensive evaluation and treatment strategies are crucial for pulmonary hypertension and cor pulmonale.